期刊文献+

抗结核药物致肝损害139例临床分析 被引量:3

Clinical analysis of 139 cases of liver damage caused by anti-TB drugs
下载PDF
导出
摘要 目的探讨肺结核治疗中引起的肝功能异常的因素及其治疗原则。方法分析本院收治的肺结核患者在抗结核治疗中出现肝功能损害的临床特点。结果肺结核治疗期间肝损害除抗结核药物外,还与患者年龄、性别、营养不良、酗酒、肝病史及肺结核本身有关,根据肝损害程度保肝治疗疗效大多较好。结论预防、早期发现、及时治疗对预后佷重要,化疗要严密观察、定期监测肝功能。 Objective To probe into the factors that caused liver functions' abnormality during anti-tuberculosis treatment. Methods The clinical features of tuberculosis patients suffered liver damage during anti-TB treatment. Results In addition to anti-TB drugs, the damage of liver function were also associated with patient's age, gender, malnutrition, alcoholism, history of liver disease and tuberculosis itself. The liver-protected treatment was based on the degree of liver damage. Conclusion It's important to give early prevention and detection for prognosis. Chemotherapy should be closely observed, and liver function should be regularly monitored.
作者 刘红艳 张燕
出处 《临床肺科杂志》 2013年第11期2045-2046,共2页 Journal of Clinical Pulmonary Medicine
关键词 抗结核药 肝损害 anti-TB drugs damage of liver function
  • 相关文献

参考文献8

二级参考文献30

共引文献3766

同被引文献35

  • 1殷素素,何钟宓.抗结核药物致肝损害116例临床分析[J].华西医学,2008,23(5):1065-1067. 被引量:11
  • 2王新宏,李凤娟.健康教育对肺结核患者依从性影响的临床调查[J].陕西医学杂志,2007,36(3):356-358. 被引量:5
  • 3夏愔愔,詹思延.国内抗结核药物不良反应发生率的综合分析[J].中华结核和呼吸杂志,2007,30(6):419-423. 被引量:208
  • 4中华医学会.临床诊疗指南:结核病分册[M].北京:人民卫生出版社,2009:10-2.
  • 5Chamorro JG, Castagnino JP, Musella RM, et al. Sex, ethnieity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs [ J]. J Gastroen Hepatol,2013, 28(2) : 323 -328.
  • 6Corsini A, Bortolini M. Drug-induced liver injury: the role of drug metabolism and transport[J]. J Clin Pharmacol, 2013,53 (5) :463-474.
  • 7Leise MD, Poterucha JJ, Talwalkar JA. Drug-induced liver injury [-J] . Mayo Clin Proc, 2014, 89 (1):95-106.
  • 8Stine JG, Sateesh P, Lewis JH. Drug-induced liver injury in the elderly [J]. Curr Gastroenterol Rep, 2013, 15 ( 1 ) : 299.
  • 9Gupta VH, Amarapurkar DN, Singh M, et al. Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-inducedhepatotoxicity in Western India [- J]. J GastroenterolHepatolo, 2013,28(8) : 1368-1374.
  • 10Ramappa V, Aithal GP. Hepatotoxicity related to anti- tuberculosis drugs: mechanisms and management [-J]. J Clin Exp Hepatol, 2013,3(1) : 37-49.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部